重症监护期间新诊断心房颤动的长期影响:韩国全国性队列研究
该韩国全国性队列研究利用国民健康保险服务数据库,纳入2005至2013年间重症监护期间新诊断房颤且存活超过6个月的成人30869例,以及非ICU房颤对照269751例和无房颤对照439868例,采用倾向性评分匹配比较长期卒中/系统性栓塞和全因死亡风险。结果显示,ICU-AF组长期卒中/系统性栓塞风险较AF-control组调整HR为0.93(95%CI 0.88-0.98),较No-AF组调整HR为1.50(95%CI 1.42-1.60);长期死亡风险较AF-control组调整HR为1.73(95%CI 1.70-1.83),较No-AF组调整HR为3.20(95%CI 3.08-3.33)。排除房颤复发患者后,ICU-AF组卒中/系统性栓塞和死亡风险仍显著高于No-AF组(调整HR 1.08,95%CI 1.01-1.17),且不受重症原因及心血管或非心血管手术影响。作者认为这类患者可能需要密切随访和持续抗凝。
要点
- 重症期间新发房颤的存活者,长期卒中/系统性栓塞风险较无房颤者升高(调整HR 1.50,95%CI 1.42-1.60)。
- ICU-AF组长期死亡风险较无房颤者升高(调整HR 3.20,95%CI 3.08-3.33),较非ICU房颤者亦升高(调整HR 1.73,95%CI 1.70-1.83)。
- 排除房颤复发患者后,ICU-AF组卒中/系统性栓塞和死亡风险仍高于无房颤组(调整HR 1.08,95%CI 1.01-1.17)。
- 风险升高不受重症原因及心血管或非心血管手术影响。
- 作者认为这类患者可能需要密切随访和持续抗凝。
适用人群与场景
- 2005至2013年韩国国民健康保险服务数据库中,重症监护期间新诊断房颤且存活超过6个月的成人(ICU-AF组,30869例)。
- 对照包括非ICU房颤患者(AF-control组,269751例)和无房颤者(No-AF组,439868例)。
研究设计与关键结果
- 研究类型为韩国全国性队列研究,利用国民健康保险服务数据库,采用倾向性评分匹配比较ICU-AF、AF-control和No-AF三组的长期结局。
- ICU-AF组长期卒中/系统性栓塞风险较AF-control组调整HR 0.93(95%CI 0.88-0.98),较No-AF组调整HR 1.50(95%CI 1.42-1.60)。
- ICU-AF组长期死亡风险较AF-control组调整HR 1.73(95%CI 1.70-1.83),较No-AF组调整HR 3.20(95%CI 3.08-3.33)。
- 排除房颤复发患者后,ICU-AF组卒中/系统性栓塞和死亡风险仍显著高于No-AF组(调整HR 1.08,95%CI 1.01-1.17),且不受重症原因及心血管或非心血管手术影响。
证据类型、等级与局限
- 证据类型:韩国全国性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,重症期间新诊断房颤的存活者可能需要密切随访和持续抗凝。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: The long-term risks of thromboembolism and mortality are unknown in patients who survived following atrial fibrillation (AF) newly diagnosed during critical care.
METHODS: Using the Korean National Health Insurance Service database, we identified 30,869 adults who survived for > 6 months following AF newly diagnosed during critical care (ICU-AF), 269,751 control subjects with non-ICU AF (AF-control), and 439,868 control subjects without AF (No-AF) from 2005 to 2013. We performed propensity score matching and compared the risks of stroke/systemic embolism and all-cause mortality.
RESULTS: The adjusted hazard ratios (HRs) for long-term stroke/systemic embolism in the patients with ICU-AF were 0.93 (95% CI, 0.88-0.98) compared with the AF-control group and 1.50 (95% CI, 1.42-1.60) compared with the No-AF group. The adjusted HRs of the ICU-AF group for long-term mortality were 1.73 (95% CI, 1.70-1.83) and 3.20 (95% CI, 3.08-3.33) compared with the AF-control and No-AF groups, respectively. The risks of stroke/systemic embolism and mortality were significantly higher in the ICU-AF group than in the No-AF group after excluding patients with AF recurrence (adjusted HR, 1.08; 95% CI, 1.01-1.17), regardless of the causes of critical care and cardiovascular or noncardiovascular surgery.
CONCLUSIONS: The patients who survived following AF newly diagnosed during critical care remained at a higher risk of long-term stroke/systemic embolism and mortality than the patients without AF regardless of AF recurrence and the causes of critical care. Close follow-up and continuous anticoagulation might be needed for these patients.
参考来源
- Kim K, Yang PS, Jang E, et al. Long-Term Impact of Newly Diagnosed Atrial Fibrillation During Critical Care: A South Korean Nationwide Cohort Study. Chest. 2019. PMID: 31051171. doi:10.1016/j.chest.2019.04.011
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。